Di Ai
State Key Laboratory Of Plant Diversity And Specialty Crops, Wuhan Botanical Garden
Wuhan, 430074, China
Wuhan, 430074, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Emicizumab prophylaxis vs immune tolerance induction in children with severe hemophilia A and inhibitors: a retrospective comparison of bleeding control, quality of life, and cost.
Journal: Research and practice in thrombosis and haemostasis
Published: December 20, 2025
Machine learning estimation of FVIII pharmacokinetic parameters in Chinese children with severe Hemophilia A.
Journal: NPJ systems biology and applications
Published: September 25, 2025
The NPR7-TGA6-MYB1 module promotes anthocyanin biosynthesis and integrates salicylic acid and strigolactone signaling in apple.
Journal: The Plant cell
Published: September 01, 2025
PpTGA1 Integrates the Salicylic Acid and Jasmonic Acid Signalling Networks to Enhance Resistance to Bacterial Spot Disease in Peach.
Journal: Plant, cell & environment
Published: August 26, 2025
The Chinese Haemophilia Individualized Prophylaxis (CHIPS): A cost-effective regimen for zero joint bleeding and long-term joint health in boys with Severe Haemophilia A (SHA) on factor replacement.
Journal: Thrombosis research
Published: July 29, 2025
Ethylene regulates RGL2a homeostasis and gibberellin signaling responses by coordinating F-box protein EBF1 and kinase MPK7 in apple.
Journal: Plant physiology
Published: May 10, 2025
PpMYB123-mediated proanthocyanidin accumulation alleviates bacterial spot disease in peach.
Journal: Horticulture research
Published: January 21, 2025
Significant PK variability of plasma-derived FIX concentrates in chinese children with Haemophilia B: A fixed single-dose study of factor IX-CTBB.
Journal: Global medical genetics
Published: January 09, 2025
A comparison of My Precise Dose and WAPPS-Hemo as dosing tools for optimizing prophylaxis in children with hemophilia A treated with BAY 81-8973.
Journal: Thrombosis research
Published: December 25, 2024
Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencing.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 16, 2024
Last Updated: 09/26/2026